Covered recipient · General Payments record
JACQUELINE M ERIKSEN
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2019–2025
$1,064.49
- Reported across 58 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $374.10 | 18 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $82.40 | 5 |
| Novo Nordisk AS | $82.18 | 5 |
| Lilly USA, LLC | $79.57 | 2 |
| Astellas Pharma US Inc | $58.31 | 3 |
| GlaxoSmithKline, LLC. | $47.64 | 2 |
| ABBVIE INC. | $24.00 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2025 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $24.00 | 04/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201822477 | CMS |
| Amgen Inc. | $17.43 | 02/27/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228598831 | CMS |
| Amgen Inc. | $16.97 | 04/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228598829 | CMS |
| Amgen Inc. | $14.50 | 06/25/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1227169135 | CMS |
| Amgen Inc. | $16.67 | 10/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228598827 | CMS |
| Amgen Inc. | $16.83 | 12/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1228598825 | CMS |
| Astellas Pharma US Inc | $24.15 | 07/09/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238708180 | CMS |
| Astellas Pharma US Inc | $18.92 | 08/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238661700 | CMS |
| Astellas Pharma US Inc | $15.24 | 10/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1238675493 | CMS |
| GlaxoSmithKline, LLC. | $24.34 | 03/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190748921 | CMS |
| GlaxoSmithKline, LLC. | $23.30 | 10/01/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1190647600 | CMS |
| Lilly USA, LLC | $58.95 | 03/20/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186665921 | CMS |
| Lilly USA, LLC | $20.62 | 12/18/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1186656183 | CMS |
| Novo Nordisk Inc | $13.86 | 01/10/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188390082 | CMS |
| Novo Nordisk Inc | $16.87 | 05/07/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188132141 | CMS |
| Novo Nordisk Inc | $13.92 | 07/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188138330 | CMS |
| Novo Nordisk Inc | $18.52 | 08/28/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188167185 | CMS |
| Novo Nordisk Inc | $19.01 | 10/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1188543642 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2019, 2020, 2021, 2022, 2023, 2024, 2025
- Source files
- Dataset page · Bulk file · PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024 , PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.